Method and system for predicting susceptibility to anticancer agent
AssigneeMbd Co., Ltd.
InventorsBo Sung KU, Sang-Hyun LEE, Kwang Hak CHOI
Life of this patent
Estimating the term…
Loading patent…
AssigneeMbd Co., Ltd.
InventorsBo Sung KU, Sang-Hyun LEE, Kwang Hak CHOI
Estimating the term…
The present invention relates to a method and system for predicting treatment responsiveness to an anticancer agent by using the CODRP index, which is an anticancer agent susceptibility index obtained by calculating Z-scores of each of the cell growth factor and drug response factor, integrating the same and converting the calculated values into Z-scores. Since the method for predicting susceptibility to an anticancer agent according to the present invention predicts susceptibility to an anticancer agent based on multiple factors of the drug response factor and cell growth factor, the prediction accuracy is improved compared to the conventional method for predicting susceptibility to an anticancer agent, and by predicting and providing appropriate treatment methods to individual cancer patients at an early stage, it has the advantage of reducing the pain of cancer patients during the treatment process by minimizing the trial and error of the medical personnel in selecting anticancer agents.
A method for providing information for predicting susceptibility to an anticancer agent, comprising the following steps:
A system for predicting susceptibility to an anticancer agent, comprising:
Dependencies are inferred from the claim text.